This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
—The comments of Cooper et al regarding our article "Percutaneous Absorption of Salicylic Acid" are appreciated. Unfortunately, I think they are attempting to derive more information from our data than the study was designed to provide. We made no attempt to carefully study the pharmacokinetics of salicylic acid absorption through normal or psoriatic epidermis. The purpose of the serum salicylate levels was to determine if daily treatment would lead to accumulation and not to evaluate peak concentrations or bioavailability. While it is true that serum levels in excess of 5 mg/100 ml may have occurred before or following our fivehour samples, they could never have been much in excess of this value, and certainly never approach toxic concentration.
We made no attempt to rigidly control the quantity of gel applied or to accurately assess the activity and area involved by psoriasis because this was not necessary for the study and
Taylor JR. Pharmacokinetics of Salicylic Acid-Reply. Arch Dermatol. 1976;112(11):1610. doi:10.1001/archderm.1976.01630350076021
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: